期刊文献+
共找到456篇文章
< 1 2 23 >
每页显示 20 50 100
Relationship between hepatitis B virus associated primary hepatocellular carcinoma and alteration of tumor suppressor gene p53 被引量:2
1
作者 朱明华 GreenblattMS FeitelsonMA 《Journal of Medical Colleges of PLA(China)》 CAS 1997年第4期257-260,共4页
Objective: To explore the changes and significance of tumor suppressor gene p53 in primary hepatocellu-lar carcinoma (PHC ) with hepatitis B virus (HBV ) infection. Methods: Tumor tissues and surrounding nontumortissu... Objective: To explore the changes and significance of tumor suppressor gene p53 in primary hepatocellu-lar carcinoma (PHC ) with hepatitis B virus (HBV ) infection. Methods: Tumor tissues and surrounding nontumortissues of sixteen PHC cases were studied by Southern hybridization to detect the state of HBV-DNA in tissues, byimmunohistochemical staining to determine HBsAg, HBxAg and p53 protein, and by PCR directed sequencing toanalyse the point mutation of p53 gene exons 5 to 8. Results: Among the 16 cases. 13 cases were HBV-DNA posi-tive, 10 tumor cases and 13 nontumor tissues cases HBxAg positive, and 9 cases posltive for p53 protein. The se-quencing of p53 gene point mutation was found in 5 cases, only one of which was sited at codon 249 G to T. Con-clusion: The mutation of p53 gene codon 249 is infrequent in HBV related PHC,indicating the accumulation of p53protein in cells may be associated with expression of HBxAg. HBxAg binding to p53 protein and inactivation of p53function play important roles in the development of PHC. 展开更多
关键词 HEPATOMA hepatitis B virus X ANTIGEN tumor suppressor gene P53 mutation
在线阅读 下载PDF
Effects of multiple tumor suppressor 1 on the proliferation of human ovarian cancer HO-8910 cells
2
作者 刘淑娟 辛晓燕 +2 位作者 韩军涛 汤朝武 王德堂 《Journal of Medical Colleges of PLA(China)》 CAS 1999年第3期232-234,共3页
objective: To investigate the effects of multiple tumor suppressor 1 on the proliferation of ovarian cancer cell lines. Methods: Growth characteristics of HO-8910 (without p16 gene expression ), 8910-p16 (trans fected... objective: To investigate the effects of multiple tumor suppressor 1 on the proliferation of ovarian cancer cell lines. Methods: Growth characteristics of HO-8910 (without p16 gene expression ), 8910-p16 (trans fected with p16 gene) and 8910-pcDNA3 (transfected with the vector pcDNA3) cells were studied by comparison of the cell growth curves. DNA synthesis was also compared among the 3 kinds of cells. Results: After trans fected with p16 gene, the 8910-p16 cells were markedly inhibited in both the proliferation and DNA synthesis. There was no significant difference between the 8910-pcDNA3 cells and the HO-8910 cells. Conclusion: Multiple tumor suppressor 1 can inhibit the proliferation and DNA synthesis of human ovarian cancer HO-8910 cells. 展开更多
关键词 OVARIAN cancer MULTIPLE tumor suppressor 1 gene therapy
在线阅读 下载PDF
Expression and significance of tumor suppressor gene p16 in human ovarian neoplasm
3
作者 杨红 郑维国 辛晓燕 《Journal of Medical Colleges of PLA(China)》 CAS 1997年第1期33-34,共2页
To observe the relationship between tumor suppressor gene p16 expression and ovarian cancer occurrence and development. Metbods: Using ABC immunohistochemistry method, we investigated the expression of p16 in 72 cases... To observe the relationship between tumor suppressor gene p16 expression and ovarian cancer occurrence and development. Metbods: Using ABC immunohistochemistry method, we investigated the expression of p16 in 72 cases of ovarian neoplasm. Results: The positive rates of p16 in malignant, benign, borderline tumors and normal ovarian tissue were 7. 89%, 60.00%, 66. 67% and 83. 33%, respectively (P<0.01). In the cases whose tumors were more malignant and poorly differentiated, and who relapsed and died, the positive stainings were not discovered. Conclusiou: p16 is well related with the occurrence and development of malignant ovarian tumor. 展开更多
关键词 OVARIAN NEOPLASM P16 tumor suppressor gene IMMUNOHISTOCHEMISTRY
在线阅读 下载PDF
IDENTIFICATION OF DIFFERENTIAL GENES IN OVARIAN CANCER USING REPRESENTATIONAL DIFFERENCE ANALYSIS OF cDNA
4
作者 Hong Chen Min Wang +3 位作者 Xin-yan Wang Shan Gao Jun Wang Xiao-ming Guan 《Chinese Medical Sciences Journal》 CAS CSCD 2005年第3期185-189,共5页
Objoctive To identify differential genes between normal ovarian epithelium tissue and ovarian epithelial cancer using representational difference analysis of cDNA (cDNA-RDA). Methods cDNA-RDA was performed to ident... Objoctive To identify differential genes between normal ovarian epithelium tissue and ovarian epithelial cancer using representational difference analysis of cDNA (cDNA-RDA). Methods cDNA-RDA was performed to identify the differentially expressed sequences between cDNAs from cancer tissue and cDNAs from normal ovarian tissue in the same patient who was in the early stage of ovarian serous cystadenocarcinoma. These differentially expressed fragments were cloned and analyzed, then sequenced and compared with known genes. Results Three differentially cxpressed cDNA fragments were isolated using cDNA from normal ovarian tissue as tester and cDNA from cancer tissue as driver amplicon by cDNA-RDA. DP Ⅲ- 1 and DP Ⅲ-2 cDNA clone showed significant homology to the cDNA of alpha actin gene; DPⅢ-3 cDNA clone showed significant homology to the cDNA oftransgelin gene. Conclusion cDNA-RDA can bc used to sensitively identify the differentially expressed genes in ovarian serous cystadenocarcinoma. Ovarian serous cystadenocarcinoma involves alteration of multiple genes. 展开更多
关键词 representational difference analysis of cDNA ovarian cancer differential expressed gene tumor suppressive gene
在线阅读 下载PDF
子宫内膜癌组织相关标志物表达及其临床意义
5
作者 贺慧 董黎 +1 位作者 贺珍 胡爱侠 《成都医学院学报》 2025年第2期250-255,共6页
目的 分析细胞角蛋白7(CK7)、肿瘤抑制基因(p53)、磷酸酶与张力蛋白同源物(PTEN)、糖类抗原125(CA125)在子宫内膜癌组织中的表达,并探索上述指标与病理参数的关系。方法 选择河南省人民医院2022年1月至2023年2月收治的子宫内膜癌患者14... 目的 分析细胞角蛋白7(CK7)、肿瘤抑制基因(p53)、磷酸酶与张力蛋白同源物(PTEN)、糖类抗原125(CA125)在子宫内膜癌组织中的表达,并探索上述指标与病理参数的关系。方法 选择河南省人民医院2022年1月至2023年2月收治的子宫内膜癌患者143例作为研究组,随访18个月,失访4例,最终纳入139例,根据随访期间是否复发分为复发组52例、未复发组87例,另外随机选取该院因良性疾病行子宫切除术的患者50例作为对照组。比较研究组和对照组CK7、p53、PTEN、CA125表达水平,分析上述指标表达与临床病理特征的关系,比较复发组和未复发组血清CK7、p53、PTEN、CA125水平,并进行多因素Logistic回归分析和预测价值分析。结果 研究组CK7、p53、CA125阳性率(74.10%、66.91%、88.49%)高于对照组(24.00%、20.00%、16.00%),PTEN阳性率(15.11%)低于对照组(78.00%)(P<0.05)。Ⅲ~Ⅳ期、低分化、有肌层浸润及有淋巴结转移的子宫内膜癌患者癌组织中CK7、p53、CA125表达水平高于Ⅰ~Ⅱ期、中高分化、无肌层浸润及无淋巴结转移者,而PTEN表达水平低于Ⅰ~Ⅱ期、中高分化、无肌层浸润及无淋巴结转移者(P<0.05)。与未复发组比较,复发组血清CK7、p53、CA125水平更高(P<0.05),血清PTEN水平更低(P<0.05)。血清CK7、p53、CA125水平偏高、血清PTEN水平偏低是子宫内膜癌患者术后复发的危险因素(P<0.05)。ROC分析显示,血清CK7、p53、PTEN、CA125联合检测的AUC值为0.938,高于4项指标单独检测(P<0.05),敏感度和特异度分别为86.54%、88.51%。结论 子宫内膜癌患者病情进展和复发与癌组织中CK7、p53、CA125表达上调,PTEN表达下调密切相关,且上述4项指标联合检测预测复发更具优势。 展开更多
关键词 子宫内膜癌 细胞角蛋白7 肿瘤抑制基因 磷酸酶与张力蛋白同源物 糖类抗原125 病理特征
在线阅读 下载PDF
MR高分辨率血管壁成像联合血清elabela、TSG-6检测对颈动脉斑块稳定性的评估价值
6
作者 李华莉 罗敏 姜萍 《影像科学与光化学》 2025年第1期95-100,107,共7页
目的:探究磁共振成像(magnetic resonance imaging,MRI)高分辨率血管壁成像联合血清elabela、肿瘤坏死因子α刺激基因-6(TSG-6)检测对颈动脉斑块稳定性的评估价值。方法:收集2022年12月至2023年12月在本院接受颈动脉内膜剥脱手术的110... 目的:探究磁共振成像(magnetic resonance imaging,MRI)高分辨率血管壁成像联合血清elabela、肿瘤坏死因子α刺激基因-6(TSG-6)检测对颈动脉斑块稳定性的评估价值。方法:收集2022年12月至2023年12月在本院接受颈动脉内膜剥脱手术的110例患者的临床资料。根据病理诊断,患者被分为稳定组(61例)和不稳定组(49例)。采用酶联免疫吸附试验(enzyme linked im-munosorbent assay,ELISA)测定血清elabela、TSG-6水平。通过Spearman相关性分析血清ela-bela、TSG-6水平与颈动脉不稳定斑块的关系,并利用受试者操作特征(receiver operator character-istic,ROC)曲线评估血清elabela、TSG-6在诊断颈动脉斑块稳定性中的价值。结果:不稳定组血清elabela、TSG-6水平均显著高于稳定组(P<0.05),并且与颈动脉不稳定斑块的形成呈正相关(相关系数分别为0.469和0.502,P<0.05)。血清elabela和TSG-6的ROC曲线下面积(area under ROC curve,AUC)分别为0.751和0.723,表明这两种标志物在诊断颈动脉斑块稳定性方面具有一定的准确性。MRI高分辨率血管壁成像联合血清elabela、TSG-6能够更准确地诊断颈动脉斑块的稳定性。结论:MRI高分辨率血管壁成像联合血清elabela、TSG-6检测,在颈动脉粥样硬化患者斑块稳定性方面展现出临床价值,可以作为颈动脉斑块稳定性评估的有效工具。 展开更多
关键词 MRI高分辨率血管壁成像 颈动脉斑块 血清elabela 肿瘤坏死因子α刺激基因-6
在线阅读 下载PDF
cGAS-STING通路在肿瘤免疫治疗中的作用机制与研究进展
7
作者 王适豪 石万瑞 +1 位作者 刘轶 张皓 《高等学校化学学报》 北大核心 2025年第1期66-75,共10页
环磷酸鸟苷酸合成酶[Cyclic guanosine monophosphate-adenosine monophosphate(GMP-AMP)synthase,cGAS蛋白]-干扰素刺激因子(Stimulator of interferon genes,STING蛋白)(cGAS-STING)信号通路是识别细胞质中异常DNA、激活先天免疫应答... 环磷酸鸟苷酸合成酶[Cyclic guanosine monophosphate-adenosine monophosphate(GMP-AMP)synthase,cGAS蛋白]-干扰素刺激因子(Stimulator of interferon genes,STING蛋白)(cGAS-STING)信号通路是识别细胞质中异常DNA、激活先天免疫应答系统的重要通路.cGAS蛋白在识别细胞质内异常DNA后,可催化三磷酸腺苷(ATP)和三磷酸鸟苷(GTP)合成环状鸟苷酸二磷酸腺苷(Cyclic GMP-AMP,cGAMP).cGAMP作为第二信使激活STING蛋白,促进I型干扰素的释放,从而引起一系列免疫反应.cGAS-STING通路可以调控肿瘤的转移和增长,参与抗肿瘤的先天免疫反应,探究cGAS-STING通路的作用机制在肿瘤免疫治疗中具有重要意义.本综合评述介绍了cGAS-STING通路的作用机制,概述了目前在抗肿瘤免疫治疗中激活cGAS-STING通路的各类策略. 展开更多
关键词 环磷酸鸟苷酸合成酶-干扰素刺激因子信号通路 肿瘤 免疫治疗 纳米药物
在线阅读 下载PDF
miR-217、USP10、LZTS1在晚期非小细胞肺癌癌组织与癌旁组织中的表达及与临床疗效的关系
8
作者 谢芳芳 樊静 李建梅 《临床误诊误治》 2025年第8期73-79,共7页
目的探讨微小核糖核酸-217(miR-217)、泛素特异性肽酶10(USP10)、亮氨酸拉链肿瘤抑制基因1(LZTS1)在晚期非小细胞肺癌(NSCLC)癌组织与癌旁组织中的表达及与临床疗效的关系。方法选取2021年1月至2023年1月收治的晚期NSCLC患者108例作为... 目的探讨微小核糖核酸-217(miR-217)、泛素特异性肽酶10(USP10)、亮氨酸拉链肿瘤抑制基因1(LZTS1)在晚期非小细胞肺癌(NSCLC)癌组织与癌旁组织中的表达及与临床疗效的关系。方法选取2021年1月至2023年1月收治的晚期NSCLC患者108例作为研究对象,比较癌组织与癌旁组织中miR-217、USP10、LZTS1水平:均给予个体化治疗,根据1年后随访病情分为疾病控制组与疾病进展组,比较2组临床资料及癌组织miR-217、USP10、LZTS1水平,分析miR-217、USP10、LZTS1水平与临床疗效的关系及预测价值,对比不同miR-217、USP10、LZTS1表达患者1年生存率。结果晚期NSCLC患者癌组织miR-217、LZTS1 mRNA低于癌旁组织,USP10 mRNA高于癌旁组织(P<0.01);108例晚期NSCLC患者经治疗后,将44例部分缓解患者和33例稳定患者纳入疾病控制组,31例进展患者纳入疾病进展组;疾病进展组癌组织miR-217、LZTS1 mRNA低于疾病控制组,USP10 mRNA高于疾病控制组(P<0.01);多因素logistic回归分析显示,在校正其他因素前后,miR-217、USP10、LZTS1均是晚期NSCLC患者临床疗效的独立影响因素(P<0.01)。癌组织miR-217、USP10、LZTS1联合预测晚期NSCLC患者疾病进展的价值明显高于各指标单独预测(P<0.05)。Kaplan-Meier曲线分析显示,miR-217、LZTS1低表达患者1年生存率为35.00%(14/40)、31.71%(13/41)低于高表达患者的69.70%(46/66)、72.31%(47/65),USP10高表达患者1年生存率为32.61%(15/46)低于低表达患者的75.00%(45/60),差异有统计学意义(P<0.05)。结论miR-217、LZTS1在晚期NSCLC患者癌组织中呈低表达,USP10呈高表达,三者与其临床疗效独立相关,能有效预测临床疗效,且与生存预后联系紧密。 展开更多
关键词 肺肿瘤 非小细胞 晚期 微小核糖核酸-217 泛素特异性肽酶10 亮氨酸拉链肿瘤抑制基因1 临床疗效 预测价值 生存曲线
在线阅读 下载PDF
Hepatocellular carcinoma-derived exosomal miRNA-761 regulates the tumor microenvironment by targeting the SOCS2/JAK2/STAT3 pathway 被引量:4
9
作者 Xiao-hu Zhou Hao Xu +5 位作者 Chang Xu Ying-cai Yan Lin-shi Zhang Qiang Sun Wei-lin Wang Yan-jun Shi 《World Journal of Emergency Medicine》 SCIE CAS CSCD 2022年第5期379-385,共7页
BACKGROUND:Exosomes and exosomal microRNAs have been implicated in tumor occurrence and metastasis.Our previous study showed that microRNA-761(miR-761)is overexpressed in hepatocellular carcinoma(HCC)tissues and that ... BACKGROUND:Exosomes and exosomal microRNAs have been implicated in tumor occurrence and metastasis.Our previous study showed that microRNA-761(miR-761)is overexpressed in hepatocellular carcinoma(HCC)tissues and that its inhibition affects mitochondrial function and inhibits HCC metastasis.The mechanism by which exosomal miR-761 modulates the tumor microenvironment has not been elucidated.METHODS:Exosomal miR-761 was detected in six cell lines.Cell counting kit-8(CCK-8)and transwell migration assays were performed to determine the function of exosomal miR-761 in HCC cells.The luciferase reporter assay was used to analyze miR-761 target genes in normal fi broblasts(NFs).The inhibitors AZD1480 and C188-9 were employed to determine the role of the Janus kinase 2/signal transducer and activator of transcription 3(JAK2/STAT3)signaling pathway in the transformation of cancer-associated fi broblasts(CAFs).RESULTS:In this study,we characterized the mechanism by which miR-761 reprogrammed the tumor microenvironment.We found that HCC-derived exosomal miR-761 was taken up by NFs.Moreover,HCC exosomes aff ected the tumor microenvironment by activating NFs via suppressor of cytokine signaling 2(SOCS2)and the JAK2/STAT3 signaling pathway.CONCLUSIONS:These results demonstrated that exosomal miR-761 modulated the tumor microenvironment via SOCS2/JAK2/STAT3 pathway-dependent activation of CAFs.Our fi ndings may inspire new strategies for HCC prevention and therapy. 展开更多
关键词 EXOSOMES Janus kinase 2/signal transducer and activator of transcription 3(JAK2/STAT3)signaling pathway microRNA-761 suppressor of cytokine signaling 2 tumor microenvironment
在线阅读 下载PDF
妊娠期糖尿病患者Furin水平及Furin基因P1启动区r2071410 C/T位点多态性分析
10
作者 黄海 杨秋娥 刘爱胜 《生物医学工程与临床》 2025年第1期93-98,共6页
目的了解妊娠期糖尿病(GDM)患者弗林蛋白酶(Furin)、肿瘤生长因子-β(TGF-β)、血管内皮生长因子(VEGF)、稳态模型胰岛素抵抗指数(HOMA-IR)及丝氨酸蛋白酶抑制剂B1(SerpinB1)水平及Furin基因P1启动区r2071410 C/T位点多态性,并探讨其与... 目的了解妊娠期糖尿病(GDM)患者弗林蛋白酶(Furin)、肿瘤生长因子-β(TGF-β)、血管内皮生长因子(VEGF)、稳态模型胰岛素抵抗指数(HOMA-IR)及丝氨酸蛋白酶抑制剂B1(SerpinB1)水平及Furin基因P1启动区r2071410 C/T位点多态性,并探讨其与深圳地区GDM的易感性。方法选择2021年10月至2024年3月GDM确诊患者116例(GDM组),年龄21~45岁,平均年龄28.23岁;孕前身体质量指数18.54~26.13 kg/m^(2),平均身体质量指数21.66 kg/m^(2);产次0~2次,平均产次0.34次;采血孕周24~26周,平均采血孕周24.73周。同期口服葡萄糖耐量试验正常孕妇89例(对照组),年龄20~46岁,年龄28.71岁;孕前身体质量指数19.82~27.34 kg/m^(2),平均身体质量指数21.86 kg/m^(2);产次0~3次,平均产次0.32次;采血孕周24~27周,平均采血孕周25.06周。采用酶联免疫吸附分析法检测Furin、TGF-β、VEGF及SerpinB1水平,并采用葡萄糖氧化酶法和化学发光免疫法测定空腹血糖(FPG)和胰岛素(Ins)水平,计算HOMA-IR。同时用反转录-实时荧光定量聚合酶链式反应法分析Furin基因P1启动区r2071410 C/T位点多态性。结果GDM组Furin、TGF-β、VEGF及HOMA-IR水平[(183.39±56.17)pg/mL、(25.05±5.46)ng/L、(29.30±6.21)ng/L及3.65±0.76]明显高于对照组[(61.42±15.83)pg/mL、(12.49±2.52)ng/L、(11.52±3.28)ng/L及1.82±0.34],而SerpinB1水平[(41.38±9.35)μg/L]明显低于对照组[(72.47±15.69)μg/L],差异有统计学意义(P<0.05)。经Pearson相关分析,Furin与TGF-β、VEGF及HOMA-IR水平呈正相关,而与SerpinB1水平呈负相关(r=0.6402、0.7154、0.7826、-0.7163,P<0.05);GDM组TT基因型和T等位基因频率分别为50.86%和60.78%,明显高于对照组8.99%和19.10%,而CC基因型和C等位基因频率分别为29.31%和39.22%,明显低于对照组70.79%和80.90%,差异有统计学意义(P<0.05);但CT基因型(19.83%vs 20.22%)差异无统计学意义(P>0.05);不同基因型GDM患者Furin水平差异有显著统计学意义(P<0.001),其中TT基因型Furin水平(253.75 pg/mL±71.42 pg/mL)明显高于CC和CT基因型(106.28 pg/mL±25.74 pg/mL,116.89 pg/mL±30.12 pg/mL),差异有显著统计学意义(P<0.01),但CC与CT基因型之间差异无统计学意义(P>0.05)。结论Furin、TGF-β、VEGF及HOMA-IR水平在GDM患者血清中明显升高,而SerpinB1水平明显降低,且互相之间存在密切关系。同时Furin基因P1启动区r2071410 C/T位点基因突变呈多态性,且不同基因型Furin水平存在很大差异,可能与深圳地区GDM发病密切相关。 展开更多
关键词 妊娠期糖尿病 弗林蛋白酶(Furin) 肿瘤生长因子β(TGF-β) 血管内皮生长因子(VEGF) 稳态模型胰岛素抵抗指数(HOMA-IR) 丝氨酸蛋白酶抑制剂B1(Serpin B1) 基因多态性
在线阅读 下载PDF
An experimental study on the expression of SV40 large tumor antigen in human brain tumors
11
作者 章翔 甄海宁 +5 位作者 李安民 张志文 黄文晋 张萍 梁景文 刘先珍 《Journal of Medical Colleges of PLA(China)》 CAS 2000年第1期1-6,共6页
Objective: To study the role of SV40 early region gene coding product large tumor antigen(Tag) expression and the interaction between Tag and tumor suppressors p53 and pRb in human brain tumorigenesis. Methods: Tag wa... Objective: To study the role of SV40 early region gene coding product large tumor antigen(Tag) expression and the interaction between Tag and tumor suppressors p53 and pRb in human brain tumorigenesis. Methods: Tag was investigated by immunoprecipitation followed by silver staining and Western blot in 65 cases of human brain tumors and 8 cases of normal brain tissues. Tag-p53 and Tag-pRb complexes were screened by immunoprecipitation and Western blot in 18 and 15 Tag positive tumor tissues respectively. Results: SV40 Tag was expressed generally in human brain tumors, its positive rate was 66. 2% (43 /65). However, Eight normal brain tissues were all negative for Tag, there was significant difference between them(P < 0. 05). Tag-p53 complex was detected in all of 18 Tag positive tumors as well as Tag-pRb complex in all of 15 Tag positive tumors. Conclnsion: SV40 Tag expression is associated with human brain tumorigenesis. The inactivation of p53 and pRh due to the formation of Tag-p53 and Tag-pRb complexes is possibly an important mechanism in the etiopathogenesis of human brain tumors. 展开更多
关键词 simian virus 40 (SV40) large tumor ANTIGEN (Tag) brain tumor p53 PRB tumor suppressor
在线阅读 下载PDF
Gene expression and cellular localizations of tumor necrosis factor-α at the site of implanted bovine cancellous bone in mice
12
作者 郭征 胡蕴玉 +1 位作者 王剑波 张传山 《Journal of Medical Colleges of PLA(China)》 CAS 1997年第4期304-307,共4页
The objective of this study was to determine if mRNA encoding for tumor necrosls factor-α(TNFα) was present at the site of implanted bovine cancellous bone and to observe the cellular localizations. The particles of... The objective of this study was to determine if mRNA encoding for tumor necrosls factor-α(TNFα) was present at the site of implanted bovine cancellous bone and to observe the cellular localizations. The particles of bovine cancellous bone treated by special chemical reagents were implanted in the mouse’s muscle pouch. removed 5.10 and 20 days after implantation, and the specimens were processed for determining the expression and cellular localizations of TNFα mRNA, which was performed by a nonradioactive in situ hybridization technique. The results showed that (1) 5, 10 and 20 days after transplantation, the TNFα mRNA expressions were positive, andthe positive rate of expression was the highest by 10 days (P<0. 05 ). (2)There was strong hybridization signal localization to the nuclei of morphologically ldentifiable monocytes and multinucleated giant cells. (3)Similar activity was detected in the cytoplasm and (or) nuclei of partial adjacent mesenchymal cells, fibroblasts as well as striated muscle fibers. This finding tended to indicate that mRNA encoding for TNFα was intensely expressed in several kinds of cells and that TNFα seemed to be of importance for the modulation of local cellular immunity in the region of implanted xenogeneic bone. 展开更多
关键词 bone GRAFT tumor NECROSIS factor-α gene expression in SITU HYBRIDIZATION MICE
在线阅读 下载PDF
Construction of murine interleukin-3 and murine tumor necrosis factor-α hepatoma-specific retroviral vectors and specific expression in the hepatoma cell lines
13
作者 曹广文 杜平 +2 位作者 杨文国 戚中田 孔宪涛 《Journal of Medical Colleges of PLA(China)》 CAS 1995年第4期253-258,共6页
PSV23SMTNF and pSPMoIL-3 plasmids were cleaved to release murine interleukin-3 (mIL-3)and murine tumor necrosis factor (mTNF) complementary DNA (cDNA) resectively.The 3'terminal instable sequence of mIL-3 cDNA was... PSV23SMTNF and pSPMoIL-3 plasmids were cleaved to release murine interleukin-3 (mIL-3)and murine tumor necrosis factor (mTNF) complementary DNA (cDNA) resectively.The 3'terminal instable sequence of mIL-3 cDNA was deleted with Nco I digestion. Both cDNAs 展开更多
关键词 INTERLEUKIN-3 tumor NECROSIS factor gene transferi HEPATOMA ALBUMIN enhancer/promoter
在线阅读 下载PDF
THE CORRELATIONS OF RETINOIC ACID RECEPTOR-α AND ESTROGEN RECEPTOR EXPRESSION IN HUMAN BREAST CANCER CELL LINES AND TUMORS
14
作者 余黎明 邵志敏 +2 位作者 蔡三军 韩企夏 沈镇宙 《Chinese Medical Sciences Journal》 CAS CSCD 1998年第3期154-157,共4页
Retinoic acid receptor-α (RAR α) plays a major role in the growth inhibitory effect of retinoic acid on human breast cancer cells, may be it could serve as an indicator to guide the treatment and prevent of breast c... Retinoic acid receptor-α (RAR α) plays a major role in the growth inhibitory effect of retinoic acid on human breast cancer cells, may be it could serve as an indicator to guide the treatment and prevent of breast cancer with retinoic acid in clinic. All previous researchs were based on observing the changes of RAR α mRAN expression. In this study, the expression of RAR α in human breast cell lines was studied by Northern Blot, Western Blot and Immunohistochemistry in mRNA level and protein level. Results showed that RAR α protein expression was correlated with RAR α mRNA expression. RAR α mRNA ex- pression was higher in estrogen receptor (ER)-positive human breast cancer cell lines than in ER-negative ones. So was RAR a protein expression. Both RAR α mRNA amd RAR α protein expression were associ- ated with ER status. The expression of RAR α and the relationship between RAR a and ER status were al- so determined by immunohistochemistry in 58 human primary breast cancer tumors. 37 (63. 8% ) tumors were ER-positive and of these 28 (75. 7% ) were also RAR α -positive. The coexpression of ER and RAR a was statistically significant (P<0. 01, by X^2 contingency analysis). It was reported that RAR α expres- sion in cultured breast cancer cells was regulated by estrogen acting via the ER. Our study demonstrated that RAR α expression may be modulated in breast cancer in vivo by estrogen via ER. 展开更多
关键词 breast tumor gene expression nuclear receptor
在线阅读 下载PDF
SURGICAL TREATMENT OF MALIGNANT ESOPHAGEAL TUMORS IN PUMC HOSPITAL
15
作者 郭惠琴 李泽坚 +5 位作者 张帆 张志庸 徐乐天 李卫东 王秀琴 吴旻 《Chinese Medical Sciences Journal》 CAS CSCD 2001年第4期214-217,共4页
To study how to prolong the postoperative survival time of the patients with malignant esophageal tumors. The clinical data of 1098 patients with malignant esophageal tumors from 1961 to 1992 were retrospectively anal... To study how to prolong the postoperative survival time of the patients with malignant esophageal tumors. The clinical data of 1098 patients with malignant esophageal tumors from 1961 to 1992 were retrospectively analyzed. The deletion of fragile histamine triplet (FHIT) gene (a tumor suppressor gene) in 30 fresh esophageal samples obtained in 1996 was detected with PCR and RT PCR method. The resectability was raised gradually and the operative morbidity and mortality decreased year by year, but there was no significant improvement on the postoperative 5 year survival rate. Delayed diagnosis and irradical resection influenced the long term survival. The deletion of cDNA of FHIT gene was 64.2% in esophageal cancer and 20% in the resected margin of the cancer. We believe that high grade atypical hyperplasia in esophageal epithelium and deletion of FHIT gene in esophageal cancer and its resected margin are pathological and molecular markers for early diagnosis of esophageal cancer respectively, and the latter may be one of the molecular markers for the resection. Early diagnosis and treatment, radical resection, and postoperative nutritional support are very important for the improvement of the postoperative survival time of the patients. 展开更多
关键词 malignant esophageal tumors early diagnosis FHIT gene
在线阅读 下载PDF
卵巢支持-间质细胞瘤临床病理学及分子遗传学特征分析 被引量:1
16
作者 李振乾 李盼 +1 位作者 李道明 陈奎生 《河南医学研究》 CAS 2024年第11期1931-1935,共5页
目的 探讨卵巢支持-间质细胞瘤(SLCT)的临床病理学特征及分子遗传学特征。方法 回顾郑州大学第一附属医院收治的13例SLCT患者的临床病理资料,Sanger测序检测DICER1热点区域体细胞突变(第24、25外显子相关位点),完善随访资料,分析DICER1... 目的 探讨卵巢支持-间质细胞瘤(SLCT)的临床病理学特征及分子遗传学特征。方法 回顾郑州大学第一附属医院收治的13例SLCT患者的临床病理资料,Sanger测序检测DICER1热点区域体细胞突变(第24、25外显子相关位点),完善随访资料,分析DICER1突变与SLCT临床病理特征的相关性,并检索相关文献。结果 SLCT中位数年龄24岁,首发临床症状为月经失调、盆腔包块或下腹胀痛;镜下见管状、条索状及肉瘤样等区域,免疫组化表达CR、WT-1、Inhibin-α、SF-1等。预后随访中30.8%(4/13)患者复发,76.9%(10/13)检测到DICER1基因突变,且DICER1基因突变在年龄上差异有统计学意义(P<0.05),在组织学分化程度、肿瘤是否复发上差异无统计学意义(P>0.05),有异源性分化者DICER1突变率可能高。结论 SLCT形态多样,诊断需要结合临床特点、免疫组化及DICER1基因检测。DICER1突变多发生于年轻患者,与组织学分化、肿瘤是否复发的关系需进一步研究。 展开更多
关键词 卵巢支持-间质细胞肿瘤 病理特征 DICER1基因
在线阅读 下载PDF
杜仲协同拟茎点霉XP-8合成木脂素类的条件优化及其功能活性
17
作者 朱静 陈晖 +1 位作者 陈亚蓝 师俊玲 《食品工业科技》 CAS 北大核心 2024年第15期360-368,共9页
对杜仲协同拟茎点霉XP-8生物合成松脂醇(Pinoresinol,Pin)、松脂醇单葡萄糖苷(Pinoresinol-4-O-β-Dglucopyranoside,PMG)和松脂醇二葡萄糖苷(Pinoresinol diglucoside,PDG)的条件进行优化,研究培养方式、杜仲添加量和静息处理时间对Pin... 对杜仲协同拟茎点霉XP-8生物合成松脂醇(Pinoresinol,Pin)、松脂醇单葡萄糖苷(Pinoresinol-4-O-β-Dglucopyranoside,PMG)和松脂醇二葡萄糖苷(Pinoresinol diglucoside,PDG)的条件进行优化,研究培养方式、杜仲添加量和静息处理时间对Pin、PMG和PDG产量的影响,并对相关产物的抗氧化性和抑癌性进行研究。结果表明,3%杜仲PDB培养基培养菌体并静息处理5 d时Pin、PMG和PDG产量较高。该条件下代谢产物液对DPPH和ABTS+自由基的清除能力显著高于杜仲空白培养基,说明发酵过程中产生了增强抗氧化功能的物质。其还能抑制肝癌细胞HepG-2的增殖,通过纯品验证活性说明,Pin是其中主要抑制癌细胞的活性成分,代谢产物液抑制肝癌细胞的作用是一种协同效应。 展开更多
关键词 木脂素类物质 拟茎点霉XP-8 杜仲 抗氧化 抑癌
在线阅读 下载PDF
靶向肿瘤驱动基因的胃癌治疗研究进展 被引量:1
18
作者 吴世英 徐平龙 张飞 《浙江大学学报(医学版)》 CAS CSCD 北大核心 2024年第1期73-83,共11页
随着胃癌致病机制深入解析及胃癌驱动基因的鉴定,靶向胃癌驱动基因的药物逐渐应用临床。其中,曲妥珠单抗作为首个胃癌靶向药物,通过靶向过表达的人表皮生长因子受体2(HER2)抑制肿瘤细胞的增殖、生存和转移等过程,已成为HER2阳性胃癌患... 随着胃癌致病机制深入解析及胃癌驱动基因的鉴定,靶向胃癌驱动基因的药物逐渐应用临床。其中,曲妥珠单抗作为首个胃癌靶向药物,通过靶向过表达的人表皮生长因子受体2(HER2)抑制肿瘤细胞的增殖、生存和转移等过程,已成为HER2阳性胃癌患者的一线治疗药物。雷莫芦单抗则通过靶向血管内皮生长因子受体2(VEGFR2)抑制肿瘤血管生成,用于晚期胃癌患者的二线治疗。此外,贝马利珠单抗和佐妥昔单抗分别靶向过度表达的成纤维细胞生长因子受体2(FGFR2)和紧密连接蛋白18.2(CLDN18.2),在临床试验中显著延长胃癌患者的无进展生存期和总生存期。本文回顾了靶向HER2、VEGF、FGFR2、CLDN18.2和MET等肿瘤驱动基因的胃癌治疗策略,介绍了肿瘤驱动基因在胃癌进程中的作用及其靶向药物的应用,以期为胃癌靶向治疗药物的研发和临床应用提供参考。 展开更多
关键词 胃癌 驱动基因 靶向治疗 临床试验 综述
在线阅读 下载PDF
中医药调节髓源性抑制细胞失调在恶性肿瘤中的研究进展 被引量:1
19
作者 孟雪 谢玉龙 +2 位作者 朱旭 张晓兰 李峻 《中国医药导报》 CAS 2024年第21期59-64,共6页
髓源性抑制细胞(MDSCs)是一组具有免疫调节作用的髓系细胞。近年来,MDSCs在恶性肿瘤、自身免疫性疾病、感染性疾病、妊娠等领域受到广泛关注,尤其在恶性肿瘤中研究最为深入。文章概述了MDSCs及其在肿瘤微环境及恶性肿瘤治疗中的研究,聚... 髓源性抑制细胞(MDSCs)是一组具有免疫调节作用的髓系细胞。近年来,MDSCs在恶性肿瘤、自身免疫性疾病、感染性疾病、妊娠等领域受到广泛关注,尤其在恶性肿瘤中研究最为深入。文章概述了MDSCs及其在肿瘤微环境及恶性肿瘤治疗中的研究,聚焦于中医药调控MDSCs介导的免疫失衡问题,总结了中医药调节MDSCs失调在恶性肿瘤中的研究进展。文章通过对已有文献的分析,揭示中药单体、中药复方等通过抑制MDSCs的扩增、限制MDSCs激活、诱导MDSCs分化成熟、阻止MDSCs的募集等方式多途径、多靶点发挥作用,改善免疫抑制状态,从而达到抗肿瘤效果,文末提出中医药对MDSCs调控作用的研究方面尚存在的问题,以期为未来的恶性肿瘤临床治疗和药物开发提供参考。 展开更多
关键词 髓源性抑制细胞 中医药 恶性肿瘤 免疫调节 研究进展
在线阅读 下载PDF
含砷中药青黄散方案治疗超高龄伴TP53突变高危骨髓增生异常综合征1例并文献复习
20
作者 郭秋月 高文欣 +4 位作者 陈卓 王德秀 周庆兵 刘驰 李柳 《中国医药导报》 CAS 2024年第19期183-187,共5页
骨髓增生异常综合征(MDS)是起源于造血干细胞的克隆性、髓系肿瘤性疾病,其伴原始细胞增多亚型及伴肿瘤蛋白53(TP53)基因突变均与高危疾病预后分层相关,其中TP53基因突变还与治疗耐药相关。高龄MDS患者的器官功能下降,合并症多,移植不可... 骨髓增生异常综合征(MDS)是起源于造血干细胞的克隆性、髓系肿瘤性疾病,其伴原始细胞增多亚型及伴肿瘤蛋白53(TP53)基因突变均与高危疾病预后分层相关,其中TP53基因突变还与治疗耐药相关。高龄MDS患者的器官功能下降,合并症多,移植不可行,且多数不能耐受化疗、去甲基化药物治疗。患者为超高龄男性,确诊MDS伴原始细胞增多Ⅰ型,初诊时全血细胞进行性下降且需输血支持,修订版国际预后评分系统极高危,伴TP53基因突变。与同类患者比较,应用含砷中药青黄散方案治疗后中位生存期延长,血象三系有不同程度改善,生活质量提高,未发生治疗相关不良反应,耐受性良好,达到高龄MDS患者提高生活质量、延长生存期的治疗目标。本文回顾患者病历资料及应用含砷中药青黄散方案治疗过程,并结合国内外相关文献对高龄MDS的临床特点、治疗方法及相关基因突变特征进行分析,以期为高龄或超高龄预后不良MDS患者的治疗提供借鉴。 展开更多
关键词 骨髓增生异常综合征 高龄 肿瘤蛋白53基因突变 含砷中药青黄散方案
在线阅读 下载PDF
上一页 1 2 23 下一页 到第
使用帮助 返回顶部